Stocks · News reference
Maxim Group Maintains Buy on Health In Tech, Lowers Price Target to $3
Maxim Group analyst Allen Klee maintains Health In Tech (NASDAQ:HIT) with a Buy and lowers the price target from $4 to $3.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
HIT stock has given up its prior gain. Health In Tech shares were trading higher after the company announced the launch of HitRix. The company updated its FY26 revenue guidance, roughly inline with FY25.
8-K filing — Health In Tech, Inc. (HIT)
Filed: 2026-09-30 AccNo: 0001213900-26-105280 Size: 219 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Health In Tech shares are trading higher after the company announced the launch of HitRix. The company updated its FY26 revenue guidance, roughly inline with FY25.